Year archive

Pharming Group N.V. — 2008 filings

All 29 regulatory filings released by Pharming Group N.V. (PHARM) in 2008, sourced directly from the official regulator.

29 Filings

2008 Period

2008 filings (29)

Filing	Released	Lang
PHARMING ANNOUNCES REDUCTION OF € 20 MILLION DEBT AND IMPROVEMENT OF BALANCE SHEET Capital/Financing Update	2008-12-09	English
Pharming announces change in composition of Board of Supervisory Directors Board/Management Information	2008-12-01	English
PHARMING ANNOUNCES POSITIVE RESULTS FROM PRODARSAN® PHASE I STUDY Earnings Release Q4 2008	2008-11-26	English
PHARMING AND ASLAN GROUP SIGN LICENSE AGREEMENT FOR LACTOFERRIN Capital/Financing Update	2008-11-18	English
Pharming announces third quarter 2008 results Interim / Quarterly Report 9M 2008	2008-10-17	English
Pharming shareholders appoint Sijmen de Vries as new CEO Board/Management Information	2008-10-13	English
Pharming's Board of Supervisory Directors nominates new CEO Board/Management Information	2008-09-26	English
Pharming provides Business update at UBS Conference Investor Presentation	2008-09-25	English
Pharming to present at UBS Global Life Sciences Conference Investor Presentation	2008-09-18	English
Pharming to present at UBS Global Life Sciences Conference Regulatory Filings	2008-09-18	English
FDA authorizes Investigational New Drug application for recombinant human C1 inhibitor in kidney transplantation Regulatory Filings	2008-09-03	English
FDA authorizes Investigational New Drug application for recombinant human C1 inhibitor in kidney transplantation Regulatory Filings	2008-09-03	English
Pharming announces first Half 2008 Results Interim / Quarterly Report H1 2008	2008-08-05	English
Pharming included in Amsterdam Midkap Index on NYSE Euronext Regulatory Filings	2008-08-04	English
Pharming included in Amsterdam Midkap Index on NYSE Euronext Regulatory Filings	2008-08-04	English
DNAGE TO PARTICIPATE IN EUROPEAN STUDY ON BIOMARKERS OF AGEING Environmental & Social Information	2008-07-15	English
DNAGE TO PARTICIPATE IN EUROPEAN STUDY ON BIOMARKERS OF AGEING Regulatory Filings	2008-07-15	English
Pharming announces positive results from Rhucin® open-label clinical studies Earnings Release Q3 2008	2008-07-11	English
PHARMING ACQUIRES LICENSES TO KEY FIBRINOGEN PATENTS Regulatory Filings	2008-06-25	English
PHARMING ANNOUNCES POSITIVE RESULTS FROM NORTH AMERICAN RANDOMIZED TRIAL WITH RHUCIN® Regulatory Filings	2008-06-16	English
PHARMING STARTS CLINICAL PROGRAM IN AGEING DISEASES Regulatory Filings	2008-04-23	English
Pharming announces first quarter 2008 results Interim / Quarterly Report Q1 2008	2008-04-18	English
Pharming provides update on business strategy at shareholders meeting Board/Management Information	2008-04-16	English
Pharming's Annual General Meeting of Shareholders to be held in Leiden on 16 April 2008 AGM Information	2008-03-04	English
Pharming's Annual General Meeting of Shareholders to be held in Leiden on 16 April 2008 AGM Information	2008-03-04	English
Pharming concludes license agreement with Advanced Cell Technology Capital/Financing Update	2008-02-29	English
Pharming concludes license agreement with Advanced Cell Technology Regulatory Filings	2008-02-29	English
Pharming announces annual results 2007 Earnings Release FY 2007	2008-02-15	English
Pharming announces annual results 2007 Earnings Release FY 2007	2008-02-15	English

Filings by year

2026 29 filings
2025 60 filings
2024 60 filings
2023 64 filings
2022 56 filings
2021 48 filings
2020 44 filings
2019 17 filings
2018 18 filings
2017 22 filings
2016 25 filings
2015 21 filings
2014 19 filings
2013 26 filings
2012 59 filings
2011 34 filings
2010 52 filings
2009 40 filings
2008 29 filings
2007 44 filings
2006 23 filings
2005 6 filings